Innoviz Technologies grants equity awards to CBO

Innoviz Technologies Ltd. granted Chief Business Officer Elad Ben Hofstetter 57,968 share options on August 4, 2026, each for one ordinary share at an exercise price of $0.42 per share.

Rhea-AI Filing Summary

Innoviz Technologies Ltd. granted Chief Business Officer Elad Ben Hofstetter 57,968 share options on August 4, 2026, each for one ordinary share at an exercise price of $0.42 per share. These options vest one-fourth on August 4, 2027, with the remainder vesting quarterly through 2030, and expire on August 4, 2033.

The company also granted 54,112 Restricted Share Units (RSUs), each a contingent right to one ordinary share with no exercise price, vesting on the same schedule and subject to continued service. After these awards, he directly holds 286,256 ordinary shares, including 176,964 shares issuable upon vesting of multiple RSU grants.

Insider Trade Summary

Grant/Award: 112,080 shares

Grant/Award 2 txns

Insider Hofstetter Elad Ben

Role Chief Business Officer

Type	Security	Shares	Price	Value
Grant/Award	Share Option F4	57,968	$0.00	$0.00
Grant/Award	Ordinary Shares F1, F2, F3	54,112	$0.00	$0.00

Holdings After Transaction: Share Option — 57,968 contracts (Direct); Ordinary Shares — 286,256 shares (Direct)

Footnotes (4)

1. F1. Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
2. F2. Includes 176,964 ordinary shares issuable upon vesting of RSUs; of which (a) 1,782 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 7,592 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 10,454 RSUs granted February 27, 2024, with 1,788 vesting quarterly through 2027 and 8,666 vesting quarterly through 2028; (d) 21,087 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 11,341 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 30,804 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 54,112 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.
3. F3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
4. F4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Key Figures

Share options granted: 57,968 options Option exercise price: $0.42 per share RSUs granted: 54,112 RSUs +3 more

6 metrics

Share options granted 57,968 options Share options granted on August 4, 2026 to the Chief Business Officer

Option exercise price $0.42 per share Exercise price for the 57,968 share options granted August 4, 2026

RSUs granted 54,112 RSUs Restricted Share Units granted August 4, 2026, vesting through 2030

Ordinary shares after awards 286,256 shares Direct ordinary share holdings following the reported transactions

RSU-based shares included in holdings 176,964 shares Ordinary shares issuable upon vesting of RSUs included in post-transaction holdings

Option expiration date August 4, 2033 Expiration date of the share options granted on August 4, 2026

Key Terms

Restricted Share Units (RSUs), contingent right, exercise price, vesting, +1 more

5 terms

Restricted Share Units (RSUs) financial

"Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

contingent right financial

"Each RSU represents a contingent right to receive one ordinary share"

exercise price financial

"No exercise price is applicable"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

service provider financial

"subject to the Reporting Person remaining a service provider of the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity awards did Innoviz Technologies (INVZ) disclose for Elad Ben Hofstetter?

Innoviz Technologies disclosed that Chief Business Officer Elad Ben Hofstetter received 57,968 share options and 54,112 RSUs on August 4, 2026. Both awards vest one-fourth in August 2027, with the remainder vesting quarterly through 2030, subject to continued service.

How many RSUs were granted to the Innoviz Technologies (INVZ) CBO and how do they vest?

He was granted 54,112 Restricted Share Units (RSUs) on August 4, 2026. One-fourth vests on August 4, 2027, and the remaining RSUs vest quarterly through 2030, provided he remains a service provider; each RSU converts into one ordinary share with no exercise price.

What are the terms of the stock options granted by Innoviz Technologies (INVZ) to its CBO?

The CBO received 57,968 share options with an exercise price of $0.42 per share, expiring on August 4, 2033. One-fourth of these options vest on August 4, 2027, and the rest vest quarterly through 2030, conditioned on continued service.

What are Elad Ben Hofstetter’s total ordinary share holdings after this Innoviz (INVZ) Form 4?

After the reported grants, he directly holds 286,256 ordinary shares. This figure includes 176,964 ordinary shares that are issuable upon vesting of various RSU grants awarded between 2022 and 2026, with vesting schedules running through 2030.

How many RSUs remain outstanding for the Innoviz Technologies (INVZ) CBO from all grants?

Post-transaction, his holdings include 176,964 RSU-linked ordinary shares from multiple grants between 2022 and 2026. These RSUs vest on differing quarterly schedules, with final tranches extending from 2026 through 2030, all subject to continued service with Innoviz Technologies.

Are the Innoviz Technologies (INVZ) equity awards to the CBO subject to conditions?

Yes, both the RSUs and share options vest only if he remains a service provider on each vesting date. The RSUs each deliver one ordinary share without an exercise price, while the options require payment of the $0.42 exercise price per share when exercised.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:17 PM Accepted by SEC EDGAR 08/05/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hofstetter Elad Ben

(Last) (First) (Middle)

C/O INNOVIZ TECHNOLOGIES LTD.

5 URI ARIAV STREET, BUILDING C

(Street)

ROSH HA'AIN 4809202

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innoviz Technologies Ltd. [ INVZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/04/2026		A		54,112(1)	A	$0.00	286,256(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$0.42	08/04/2026		A		57,968		(4)	08/04/2033	Ordinary Shares	57,968	$0.00	57,968	D

Explanation of Responses:

1. Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

2. Includes 176,964 ordinary shares issuable upon vesting of RSUs; of which (a) 1,782 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 7,592 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 10,454 RSUs granted February 27, 2024, with 1,788 vesting quarterly through 2027 and 8,666 vesting quarterly through 2028; (d) 21,087 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 11,341 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 30,804 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 54,112 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

	/s/ Dafna Raz - Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)